Successful controlled ovarian stimulation and vitrification of oocytes in an adolescent diagnosed with myelodysplastic/pre-malignant clone with monosomy 7

References

• American College of Gynecologists (ACOG). (2014). Primary Ovarian Insufficiency in Adolescents and Young Women. Committee Opinion, No. 605, July. Retrieved from: http://www.acog.org/-/media/Committee-Opinions/Committee-on-Adolescent-Health-Care/co605.pdf?dmc=1&ts=20150722T0808503097.
   Google Scholar
• American Society for Reproductive Medicine (ASRM). (2013). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: Committee opinion paper. Fertility & Sterility, 100, 1214–1223. doi: https://doi.org/10.1016/j.fertnstert.2013.08.012.
   PubMed Web of Science ®Google Scholar
• Anderson, R.A., Mitchell, R.T., Kelsey, T.W., Spears, N., Telfer, E.E., & Wallace, H.B. (2015). Cancer treatment and gonadal function: Experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinology, 3, 556–567. doi: https://doi.org/10.1016/S2213-8587(15)00039-X.
   PubMed Web of Science ®Google Scholar
• Anderson, R.A., & Wallace, H.B. (2013). Anti-mullerian hormone, the assessment of ovarian reserve, and the reproductive outcome of the young patient with cancer. Fertility & Sterility, 99, 1469–1475. doi: https://doi.org/10.1016/j.fertnstert.2013.03.014.
   PubMed Web of Science ®Google Scholar
• Beier, R., Schulz, A., Hönig, M., Eyrich, M., Schlegel, P.-G., Holter, W., & Sykora, K.-W. (2013). Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience. Bone Marrow Transplantation, 48, 491–501. doi: https://doi.org/10.1038/bmt.2012.188.
   PubMed Web of Science ®Google Scholar
• Cakmak, H., & Rosen, M.P. (2015). Random-start ovarian stimulation in patients with cancer. Current Opinion Obstetrics & Gynaecology, 27, 215–221. doi: https://doi.org/10.1097/GCO.0000000000000180.
   PubMed Web of Science ®Google Scholar
• Coyne, K., Purdy, M., O’leary, K., Yaklic, J.L., Lindheim, S.R., & Appiah, L.A. (2014). Challenges and considerations in optimising ovarian stimulation protocols in oncofertility patients. Frontiers in Public Health, 2, 246. doi: https://doi.org/10.3389/fpubh.2014.00246.
   PubMedGoogle Scholar
• Devesa, M., Martínez, F., Coroleu, B., Rodriguez, I., González, C., & Barri, P.N. (2014). Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram. Journal of Assisted Reproduction and Genetics, 31, 583–588. doi: https://doi.org/10.1007/s10815-014-0183-6.
   PubMed Web of Science ®Google Scholar
• Engmann, L., DiLuigi, A., Schmidt, D., Nulsen, J., Maier, D., & Benadiva, C. (2008). The use of gonadotrophin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in-vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomized controlled study. Fertility & Sterility, 89, 84–91. doi: https://doi.org/10.1016/j.fertnstert.2007.02.002.
   PubMed Web of Science ®Google Scholar
• Friedler, S., Koc, O., Gidoni, Y., Raziel, A., & Ron-el, R. (2012). Ovarian response to stimulation for fertility preservation in women with malignant disease: A systematic review and meta-analysis. Fertility & Sterility, 97, 125–133. doi: https://doi.org/10.1016/j.fertnstert.2011.10.014.
   PubMed Web of Science ®Google Scholar
• HMSO. (1991). The Age of Legal Capacity (Scotland) Act. Retrieved from: http://www.legislation.gov.uk/ukpga/1991/50/section/1.
   Google Scholar
• Jeruss, J.S., & Woodruff, T.K. (2009). Preservation of fertility in patients with cancer. The New England Journal of Medicine, 360, 902–911. doi: https://doi.org/10.1056/NEJMra0801454.
   PubMed Web of Science ®Google Scholar
• Joshi, S., Savani, B.N., Chow, E.J., Gilleece, M.H., Halter, J., Jacobsohn, D.A., … Majhail, N.S. (2014). Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Bone Marrow Transplantation, 49, 477–484. doi: https://doi.org/10.1038/bmt.2013.211.
   PubMed Web of Science ®Google Scholar
• Kwan, I., Bhattacharya, S., Kang, A., & Woolner, A. (2014). Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database of Systematic Reviews, 8, CD005289. doi: https://doi.org/10.1002/14651858.CD005289.pub3.
   PubMed Web of Science ®Google Scholar
• Lambertini, M., Del Mastro, L., Percio, M.C., Anderson, C.Y., Azim, H.A., Jr., Peccatori, F.A., & Anserini, P. (2016). Cancer and fertility preservation: International recommendations from an expert meeting. BMC Medicine, 14, 1. doi: https://doi.org/10.1186/s12916-015-0545-7.
   PubMed Web of Science ®Google Scholar
• La Marca, A., & Sunkara, S.K. (2014). Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: From theory to practice. Human Reproduction Update, 20, 124–140. doi: https://doi.org/10.1093/humupd/dmt037.
   PubMed Web of Science ®Google Scholar
• Leader, A., Lishner, M., Michaeli, J., & Revel, A. (2011). Fertility considerations and preservation in haemato-oncology patients undergoing treatment. British Journal of Haematology, 153, 291–308. doi: https://doi.org/10.1111/j.1365-2141.2011.08629.x.
   PubMed Web of Science ®Google Scholar
• Lee, T.H., Liu, C.H., Huang, C.C., Wu, Y.L., Shih, Y.T., Ho, H.N., & Lee, M.S. (2008). Serum anti-müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Human Reproduction, 23, 160–167. doi: https://doi.org/10.1093/humrep/dem254.
   PubMed Web of Science ®Google Scholar
• Maltaris, T., Boehm, D., Dittrich, R., Suefert, R., & Koelbl, H. (2006). Reproduction beyond Cancer: A message of hope for young women. Gynaecologic Oncology, 103, 1109–1121. doi: https://doi.org/10.1016/j.ygyno.2006.08.003.
   PubMed Web of Science ®Google Scholar
• Mertes, H. (2015). Let’s not forget that many prepubertal girls do have other options besides ovarian tissue cryopreservation. Human Reproduction, 30, 2011–2013. doi: https://doi.org/10.1093/humrep/dev176.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). (2013). Fertility: Assessment and Treatment for People with Fertility Problems. Retrieved from: http://www.nice.org.uk/guidance/cg156/evidence/cg156-fertility-full-guideline3.
   Google Scholar
• Oktay, K., & Oktem, O. (2009). Fertility Preservation Medicine: New field in the case of cancer survivors. Pediatric Blood & Cancer, 53, 267–273. doi: https://doi.org/10.1002/pbc.22003.
   PubMed Web of Science ®Google Scholar
• Peddie, V.L., Porter, M.A., Barbour, R., Culligan, D., MacDonald, G., King, D., … Bhattacharya, S. (2012). Factors affecting decision making about fertility preservation after cancer diagnosis: A qualitative study. BJOG, 119, 1049–1057. doi: https://doi.org/10.1111/j.1471-0528.2012.03368.x.
   PubMed Web of Science ®Google Scholar
• Quinn, G.P., Murphy, D., Knapp, C., Stearsman, D.K., Bradley-Klug, K.L., Sawczyn, K., & Clayman, M.L. (2011). Who decides? Decision making and fertility preservation in teens with cancer: A review of the literature. Journal of Adolescent Health, 49, 337–346. doi: https://doi.org/10.1016/j.jadohealth.2011.01.005.
   PubMed Web of Science ®Google Scholar
• Resetkova, N., Hayashi, M., Kolp, L.A., & Christianson, M.A. (2013). Fertility preservation for prepubertal girls: Update and current challenges. Current Obstetrics and Gynecology Reports, 2, 218–225. doi: https://doi.org/10.1007/s13669-013-0060-9.
   PubMedGoogle Scholar
• Roschke, A.V., & Kirsch, I.R. (2010). Targeting karyotypic complexity and chromosomal instability of cancer cells. Current Drug Targets, 11, 1341–1350. doi: https://doi.org/10.2174/1389450111007011341.
   PubMed Web of Science ®Google Scholar
• The Royal College of Radiologists, Royal College of Obstetricians and Gynaecologists, Royal College of Physicians (RCP). (2007). The effects of cancer treatment on reproductive functions: Guidance on management. Report of a Working Party. London: RCP. Retrieved from: https://www.rcr.ac.uk/sites/default/files/publication/Cancer_fertility_effects_Jan08.pdf.
   Google Scholar
• Rustamov, O., Smith, A., Roberts, S.A., Yates, A.P., Krishnan, M., Nardo, L.G., & Pemberton, P.W. (2012). Anti-Mullerian hormone: Poor assay reproducibility in a large cohort of subjects suggests sample instability. Human Reproduction, 27, 3085–3091. doi: https://doi.org/10.1093/humrep/des260.
   PubMed Web of Science ®Google Scholar
• Thomas, D.M., Seymour, J.F., O'brien, T., Sawyer, S.M., & Ashley, D.M. (2006). Adolescent and young adult cancer: a revolution in evolution? International Medicine Journal, 36, 302–307. doi: https://doi.org/10.1111/j.1445-5994.2006.01062.x.
   Google Scholar
• van Santbrink, E.J., Donderwinkel, P.F., van Dessel, T.J., & Fauser, B.C. (1995). Gonadotrophin induction of ovulation using a step-down dose regimen: Single-centre clinical experience in 82 patients. Human Reproduction, 10, 1048–1053. doi: 10.1093/oxfordjournals.humrep.a136092.
   PubMed Web of Science ®Google Scholar